Molecular pathogenesis of B-cell chronic lymphocytic leukemia: Analysis of 13q14 chromosomal deletions

Current Topics in Microbiology and Immunology

Volumn 252, Issue , 2000, Pages 275-284

  Migliazza, A ^a   Cayanis, E ^a   Bosch Albareda, F ^a   Komatsu, H ^a   Martinotti, S ^a   Toniato, E ^a   Kalachikov, S ^a   Bonaldo, M F ^a   Jelenc, P ^a   Ye, X ^a   Rzhetsky, A ^a   Qu, X ^a   Chien, M ^a   Inghirami, G ^a   Gaidano, G ^a   Vitolo, U ^a   Saglio, G ^a   Resegotti, L ^a   Zhang, P ^a   Soares, M B ^a   Russo, J ^a   Fischer, S G ^a   Edelman, I S ^a   Efstratiadis, A ^a   Dalla Favera, R ^a   more..

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA;

B CELL LEUKEMIA; CHROMOSOME 13Q; CHROMOSOME ABERRATION; CHROMOSOME DELETION; CHRONIC LYMPHATIC LEUKEMIA; CONFERENCE PAPER; GENE MUTATION; HUMAN; HUMAN CELL; IMMUNOGLOBULIN GENE; IMMUNOGLOBULIN VARIABLE REGION; LEUKEMIA; LEUKEMOGENESIS; PATHOGENESIS; PRIORITY JOURNAL;

EID: 0033767604     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-642-57284-5_28     Document Type: Conference Paper

References (39)

1. 14q32 translocations and monosomy 13 observed in monoclonal gammopathy of undetermined significance delineate a multistep process for the oncogenesis of multiple myeloma. Intergroupe Francophone du Myelome
2. Monosomy 13 is associated with the transition of monoclonal gammopathy of undetermined significance to multiple myeloma. Intergroupe Francophone du Myelome
3. Construction of a 780-kb PAC, BAC, and cosmid contig encompassing the minimal critical deletion involved in B cell chronic lymphocytic leukemia at 13q14.3
4. ATM mutations in B-cell chronic lymphocytic leukemia
5. Minimal region of loss at 13q14 in B-cell chronic lymphocytic leukemia
6. B-cell chronic lymphocytic leukemia: A bird of a different feather
7. Characterization of nonrandom chromosomal gains and losses in multiple myeloma by comparative genomic hybridization
8. New insights into the tumor suppression function of P27(kip1)
9. Detailed molecular delineation of 13q14.3 loss in B-cell chronic lymphocytic leukemia
10. Molecular pathogenesis orb cell malignancy: The role of BCL-6
11. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia
12. Chromosome aberrations in B-cell chronic lymphocytic leukemia: Reassessment based on molecular cytogenetic analysis
13. Collection of mRNA-like non-coding RNAs
14. The murine gene p27Kip1 is haplo-insufficient for tumour suppression
15. p53 mutations in human lymphoid malignancies: Association with Burkitt lymphoma and chronic lymphocytic leukemia
16. Analysis of alterations of oncogenes and tumor suppressor genes in chronic lymphocytic leukemia
17. Multiple regions of deletion on chromosome arm 13q in head-and-neck squamous-cell carcinoma
18. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia
19. Multiple genetic alterations, 4q28, a new suppressor region, and potential gender differences in human hepatocellular carcinoma
20. Cytogenetic alterations in pituitary adenomas detected by comparative genomic hybridization
21. Cloning and gene mapping of the chromosome 13q14 region deleted in chronic lymphocytic leukemia
22. A cosmid and cDNA fine physical map of a human chromosome 13q14 region frequently lost in B-cell chronic lymphocytic leukemia and identification of a new putative tumor suppressor gene, Leu5
23. Mutation and cancer: Statistical study of retinoblastoma
24. Molecular delineation of 13q deletion boundaries in 20 patients with myeloid malignancies
25. Loss of heterozygosity at chromosome arm 13q and RB1 status in human prostate cancer
26. Identification of two distinct deleted regions on chromosome 13 in prostate cancer
27. Cloning of two candidate tumor suppressor genes within a 10 kb region on chromosome 13q 14, frequently deleted in chronic lymphocytic leukemia
28. 13q Deletions in lymphoid malignancies
29. Rearrangements of the BCL6 gene in diffuse large cell non-Hodgkin's lymphoma
30. Differential rates of somatic hypermutation in V(H) genes among subsets of chronic lymphocytic leukemia defined by chromosomal abnormalities
31. A biological role for deletions in chromosomal band 13q14 in mantle cell and peripheral t-cell lymphomas?
32. Chromosome 13 deletion in myeloma
33. Comparative genomic hybridization analysis of natural killer cell lymphoma/leukemia. Recognition of consistent patterns of genetic alterations
34. Inactivation of ataxia telangiectasia mutated gene in B-cell chronic lymphocytic leukaemia
35. Deficiency of the ATM protein expression defines an aggressive subgroup of B-cell chronic lymphocytic leukemia
36. Expressed sequences as candidates for a novel tumor suppressor gene at band 13q14 in B-cell chronic lymphocytic leukemia and mantle cell lymphoma
37. Deletion of three distinct regions on chromosome 13q in human non-small- cell lung cancer
38. Identification of a I-cM region of common deletion on 13q14 associated with human prostate cancer
39. Limiting the location of a putative human prostate cancer tumor suppressor gene at chromosome 13q14.3